Intellia Therapeutics Names Fred Cohen, M.D., to Board of Directors


You May Also Like

FibroGen Announces Third Quarter 2015 Financial Results

SAN FRANCISCO, Nov. 12, 2015 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN) (“FibroGen”), a research-based ...

XOMA Reports Fourth Quarter and Full-Year 2015 Financial Results

BERKELEY, Calif., March 09, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in ...